ASND
Ascendis Pharma A/S
$201.60
-$2.11(-1.04%)
55
Overall
--
Value
50
Tech
60
Quality
Market Cap
$12.50B
Volume
314.36K
52W Range
$118.03 - $216.45
Target Price
$254.25
EPS Estimates Overview
| Current Quarter | $-0.41 | Next Quarter | $0.09 |
| Current Year | $-2.98 | Next Year | $3.17 |
| QoQ Growth | +122.0% | YoY Growth | +206.4% |
| 3Y EPS CAGR | +0.0% | Target Price | $254.25 |
| Consensus | Buy | Upside | +26.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $201.60 | -1.0% | 314.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |